ImmunoPrecise Antibodies Ltd. (IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance efficacy, safety, therapy longevity, and patient ...
The Pharmaceutical Technology Excellence Awards winners have been announced! Download our full 50+ page report to find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback